Teledyne DALSA will preview its newest multi-line CMOS camera at The Vision Show
WATERLOO, Ontario, March 29, 2018 (GLOBE NEWSWIRE) -- Teledyne DALSA, and Teledyne e2v, both Teledyne Technologies (NYSE:TDY) companies and global leaders in image sensing technology, will be co-located at The Vision Show, in booth #517 from April 10th to 12th. Teledyne DALSA will display its newest and most advanced multi-line CMOS camera while Teledyne e2v will display their new OctoPlus range of line scan cameras for OCT applications in healthcare and industrial markets. The show takes place at the Hynes Convention Center, in Boston, Massachusetts.
The Teledyne DALSA team will present a wide-array of the company's very latest imaging technologies. In-booth demonstrations include:
- A preview of Teledyne DALSA's newest multi-line CMOS camera, offering options for monochrome, color, and NIR imaging, with fiber optic interface to an Xtium CLHS frame grabber.
- BOA spot vision sensor, which offers simple, affordable and reliable performance for automated quality inspections
- Calibir uncooled long wave infrared cameras for thermal imaging applications, featuring shutterless operations with GigE Vision®, analog and MIPI CSI-2TM interfaces
- Genie Nano cameras, feature-rich and built around industry-leading CMOS image sensors with GigE or Camera Link interface
- GEVA 4000 vison system, with over eight times the processing performance of the entry level GEVA 300, ruggedized and robust for the factory floor.
In addition to live demonstrations, show attendees will see static displays of Teledyne DALSA's newest area cameras, including the 86-megapixel Falcon4, frame grabbers, smart cameras, and image processing software. Visit the Teledyne Imaging booth to explore this wide portfolio of technologies designed for many markets and applications.
Hot Corner Topics
Teledyne DALSA subject matter experts will present in two Hot Corner topic discussions. Hot Corner discussions are open to all show attendees.
Tuesday, April 10, 1:00 pm - 3D Imaging Technologies - Raymond Boridy will present on current 3D technologies, applications and trends
- Thursday, April 12, 1:15 pm - Multi-channel line scan imaging - Mark Butler and Philip Colet will deliver a presentation focused on the possibilities of multi-channel line scan imaging
Vision Show 2018
April 10-12, 2018
Booth #517 (See booth location)
Hynes Convention Center, Boston, Massachusetts
The Vision Show is North America's largest display of machine vision and imaging components and systems. Registration is free.
About Teledyne DALSA's Machine Vision Products and Services
Teledyne DALSA is a world leader in the design and manufacture of digital imaging components for machine vision. Our image sensors, cameras, smart cameras, frame grabbers, software, and vision solutions are used in thousands of automated inspection systems around the world and across multiple industries including automotive, electronics inspection, flat panel display, medical imaging, semiconductor, packaging and general manufacturing. For more information, visit www.teledynedalsa.com/imaging.
Teledyne DALSA is an international technology leader in sensing, imaging, and specialized semiconductor fabrication. Our image sensing solutions span the spectrum from infrared through visible to X-ray; our MEMS foundry has earned a world-leading reputation. In addition, through our subsidiaries Teledyne Optech and Teledyne Caris, we deliver advanced 3D survey and geospatial information systems. Teledyne DALSA employs approximately 1400 employees worldwide and has its head office in Waterloo, Canada. For more information, visit www.teledynedalsa.com.
All trademarks are registered by their respective companies.
Teledyne DALSA reserves the right to make changes at any time without notice.
Red Javelin Communications Inc
Sales Contact: Sales.email@example.com
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6e477e62-62b0-4e23-86de-40958f87f59e
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Teledyne DALSA via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
VITEC's EZ TV Video Wall Solution Wins Best of Show Award at the 2018 NAB Show26.4.2018 19:00 | Pressmeddelande
VITEC's EZ TV Video Wall Solution Wins Best of Show Award at the 2018 NAB Show SUNNYVALE, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- VITEC, a worldwide leader in advanced video encoding and streaming solutions, today announced that the new EZ TV video wall processor, available within the award-winning EZ TV IPTV and Digital Signage Platform, was recognized with a Best of Show Award at the 2018 NAB Show from Sound & Video Contractor (SVC) magazine. Evaluated by a panel of industry experts, the Best of Show Award winners were selected based on innovation, feature set, cost efficiency, and performance in serving the industry. VITEC's video wall solution is designed to simplify deployment and management of projects involving IPTV, digital signage, and video wall content, while delivering a breathtaking visual experience. The new EZ TV video wall processors are 100 percent hardware-based, feature low-latency native playback of IPTV streams up to 4K, and support interactive content, video, a
Inspiration in Receipt of Crypto Currency Proposal26.4.2018 16:54 | Pressmeddelande
TORONTO, April 26, 2018 (GLOBE NEWSWIRE) -- Inspiration Mining Corporation ("Inspiration" or the "Corporation") (CSE:ISM) is pleased to announce that it is contemplating upon the request of Compassion Cannabis that it is allowed to accept crypto currency for settlement for any transactions that occur. The logic is that it would make for easy settlement in any jurisdiction. The Company is not adverse to this proposal, but must perform its due diligence and will table the matter at the AGM. Compassion Cannabis is an Ontario Corp., which has expertise to forward various facets of the explosive new market of the marijuana industry, including but not limited to the "Vape" market and dispensary centers for the industry. We believe this will be an extremely lucrative space with tremendous demand in the medical cannabis industry. For further information, please contact Randy Miller, Chief Executive Officer of the Corporation, at tel: 416-842-9000, www.inspirationmining.com The CSE has not revi
SNOMED International Announces Brazil as its 33rd Member26.4.2018 15:12 | Pressmeddelande
London, United Kingdom, April 26, 2018 (GLOBE NEWSWIRE) -- Brazil's Ministry of Health and SNOMED International announce that as of April 1, 2018, Brazil has joined the organization as SNOMED International's thirty-third Member. With SNOMED CT already used in various parts of the country, Brazil joined SNOMED International to support nationwide health system transformation as a foundational element of its ehealth Strategy, digiSUS. As outlined in this national strategy, the SUS Monitoring and Evaluation Department of Brazil's Ministry of Health is responsible overall for governance of the National Electronic Health Strategy and its related evaluation and development. Demonstrated through its membership in SNOMED International, Brazil has defined SNOMED CT as the chosen international reference terminology for use in its clinical systems supporting the national ehealth strategy. SNOMED CT is the world's most comprehensive health terminology. Founded in 2007 by nine charter nations, SNOME
Minerva Neurosciences to Report First Quarter 2018 Financial Results and Business Updates on May 3, 201826.4.2018 14:30 | Pressmeddelande
Management to host conference call WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the first quarter of 2018 on Thursday, May 3, 2018. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates. The live call may be accessed by dialing (877) 312-5845 for domestic callers or (765) 507-2618 for international callers and referring to conference ID number 8885379. A live webcast of the conference call will be available online in the Investors and Media section of the Company's website at ir.minervaneurosciences.com. The archived webcast will be available on the Company's website beginning approximately two hours after the event for 30 days. About Minerva Neurosciences Mine
Talend Data Fabric Now Certified on MapR Converged Data Platform Version 6.026.4.2018 14:11 | Pressmeddelande
Latest Release of Talend's Data Integration Platform Enables Powerful New Use Cases in Data Privacy, Compliance Monitoring, Claims Processing, Retail Optimization, and More REDWOOD CITY, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Talend (NASDAQ: TLND), a global leader in cloud and big data integration solutions, announced that the latest version of Talend Data Fabric is now certified for version 6.0 of the MapR Converged Data Platform, including MapR-DB and MapR-FS. The MapR Converged Data Platform is the industry's only enterprise-grade software solution that unifies big data and open source technologies with fast, native access to global event streaming, real-time database capabilities, and web-scale storage. Together, Talend and MapR provide a unified, open source-based data storage and management platform for an array of different applications, enabling organizations to harness big data in valuable ways to drive innovation and further their digital transformations. "Talend's powerf
CrownBio Launches New Humanized Target Model for Immunotherapy26.4.2018 14:00 | Pressmeddelande
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, enhances its existing portfolio of humanized drug target models (HuGEMM(TM)) by launching a new transgenic CD3E model to advance development of immuno-oncology (I/O) drugs. Novel therapeutic T-cell redirecting antibodies, including bispecific T cell engagers, show great promise in effectively treating cancer. However, development of these drugs is hampered by a lack of in vivo models that can accurately recapitulate human specific responses. CrownBio addresses this need with their new CD3E transgenic model that was validated in collaboration with and developed by NBRI of Nanjing University. The CD3E model expresses the human form of CD3E and is phenotypically normal with levels
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum